Signals mentioning Pine Labs
- Razorpay's RBI approval to aggregate in-store payments resurfaces
- Razorpay wins RBI approval to aggregate in-store payments
- New UPI MDR rules could add a high-value merchant-payments revenue stream for RediffPay
- Potential UPI MDR charges could open a new revenue stream for Paytm and Pine Labs
- FTSE rebalancing flags potential passive inflows for Pine Labs, Groww, Meesho and Lenskart
- Chandrasekaran to remain Tata Sons chairman for five years amid Noel Tata’s objection
- UPI MDR could create a ₹150-206 billion revenue pool for payment platforms
- UPI MDR rule could add ₹1.55bn in FY28 revenue for Pine Labs, says Emkay
- India to levy 0.4% MDR on eligible UPI merchant payments above Rs 2,000 from October 15
- Razorpay's RBI approval to aggregate in-store payments resurfaces from January
- Proposed UPI MDR could create Rs 16,000–20,000 crore revenue pool by FY28
- India to levy 0.4% MDR on select UPI merchant payments above Rs 2,000 from Oct 15
- Proposed 0.4% UPI MDR could reshape merchant payment costs and fintech revenues
- Proposed 0.4% MDR on UPI payments above ₹2,000 puts merchant costs in focus
- Proposed UPI MDR could unlock fresh revenue for Paytm, Pine Labs
- Paytm jumps as 0.4% MDR report signals new UPI merchant-payment revenue
- India to levy 0.4% UPI MDR on merchant payments above Rs 2,000 from Oct 15
- Paytm backs 0.4% UPI MDR above ₹2,000, calling it small-merchant protection
- Paytm gains 7.24% as 0.4% UPI MDR opens merchant-payment revenue opportunity
- UPI MDR संकेत से Paytm 7% चढ़ा; Pine Labs 8% गिरा, ब्रोकरेज ने अनुमान बदले